Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0837 vs. VKA for stroke prevention in non-valvular AF
NCT00645853Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of atecegatran metoxil in nonvalvular atrial fibrillation (NVAF), sponsored by AstraZeneca. Started Oct 2007; status: completed.
02
Drugs
atecegatran metoxil
03
Conditions
nonvalvular atrial fibrillation (NVAF)
Beyond the preview
Go deeper on NCT00645853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645853.